Silvant Capital Management LLC Raises Stock Holdings in Colgate-Palmolive Company $CL

Silvant Capital Management LLC boosted its holdings in Colgate-Palmolive Company (NYSE:CL) by 1.8% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 13,757 shares of the company’s stock after buying an additional 249 shares during the period. Silvant Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,289,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Cornerstone Wealth Management LLC increased its stake in Colgate-Palmolive by 1.2% in the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock worth $847,000 after buying an additional 110 shares in the last quarter. Aberdeen Wealth Management LLC increased its stake in Colgate-Palmolive by 0.6% in the 4th quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company’s stock worth $1,877,000 after buying an additional 125 shares in the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO increased its stake in Colgate-Palmolive by 4.0% in the 1st quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company’s stock worth $317,000 after buying an additional 130 shares in the last quarter. Continuum Advisory LLC increased its stake in Colgate-Palmolive by 17.2% in the 4th quarter. Continuum Advisory LLC now owns 893 shares of the company’s stock worth $81,000 after buying an additional 131 shares in the last quarter. Finally, KFG Wealth Management LLC increased its stake in Colgate-Palmolive by 1.5% in the 1st quarter. KFG Wealth Management LLC now owns 8,835 shares of the company’s stock worth $828,000 after buying an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.2%

Shares of NYSE:CL opened at $84.21 on Wednesday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.30. The company has a 50-day moving average price of $87.39 and a 200 day moving average price of $89.90. The company has a market cap of $68.06 billion, a price-to-earnings ratio of 23.66, a PEG ratio of 4.37 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the firm earned $0.91 EPS. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $0.52 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on CL shares. Morgan Stanley cut their price target on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Citigroup cut their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research report on Monday, August 4th. Barclays raised their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 15th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, UBS Group cut their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research report on Thursday, July 17th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $98.92.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.